Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Columbia University receives $9.6 million NIH grant for ME/CFS research center

Columbia University receives $9.6 million NIH grant for ME/CFS research center

Trial identifies genetic fault that affects treatment response in leukemia patients

Trial identifies genetic fault that affects treatment response in leukemia patients

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows

Diet and exercise have potential to improve chemotherapy effectiveness in pediatric cancer patients

Diet and exercise have potential to improve chemotherapy effectiveness in pediatric cancer patients

Forgotten strands of DNA induce 'big bang' of immune cell development

Forgotten strands of DNA induce 'big bang' of immune cell development

Researchers explore new combination approach to treat high-risk soft-tissue sarcomas

Researchers explore new combination approach to treat high-risk soft-tissue sarcomas

Inactivation of Capicua gene leads to formation of T-ALL tumors in mice, researchers find

Inactivation of Capicua gene leads to formation of T-ALL tumors in mice, researchers find

As care shifts from hospital to home, guarding against infection falls to families

As care shifts from hospital to home, guarding against infection falls to families

Make Sense campaign aims to promote better quality of life for head and neck cancer survivors

Make Sense campaign aims to promote better quality of life for head and neck cancer survivors

Research reveals sugary secrets of protein important for development and cancer progression

Research reveals sugary secrets of protein important for development and cancer progression

Research provides insight into how imbalance in neural precursor cells may contribute to brain diseases

Research provides insight into how imbalance in neural precursor cells may contribute to brain diseases

Leeds Teaching Hospitals to introduce private stem cell collection and storage option for patients

Leeds Teaching Hospitals to introduce private stem cell collection and storage option for patients

Modified blood thinner may be first promising method to prevent repercussions after TBI

Modified blood thinner may be first promising method to prevent repercussions after TBI

Arkansas professor makes strides toward developing enhanced cancer treatment

Arkansas professor makes strides toward developing enhanced cancer treatment

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Epigenetic changes triggered by cigarette smoke may be earliest step in lung cancer development

Epigenetic changes triggered by cigarette smoke may be earliest step in lung cancer development

PXi multi-application imager used for new fluorescent peptide imaging application

PXi multi-application imager used for new fluorescent peptide imaging application

Researcher develops bone marrow models to study hematological and musculoskeletal diseases

Researcher develops bone marrow models to study hematological and musculoskeletal diseases

Researchers investigate link between thyroid hormone and red blood cell production

Researchers investigate link between thyroid hormone and red blood cell production

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

FDA approves drug to treat patients with newly diagnosed CD33-positive AML